Patheon opens new US headquarters
This article was originally published in Scrip
Patheon has opened its new US headquarters and pharmaceutical development laboratory in the vicinity of Research Triangle Park, North Carolina. The pharmaceutical facility will support the firm's current US-based pharmaceutical development operations in Cincinnati and will initially offer stability studies, validation testing and analytical chemistry services. The move means that Patheon joins more than 170 other companies currently headquartered in the region, which was established nearly five decades ago. Earlier this week, Patheon said that it received a buyout offer from the private equity firm JLL, valuing Patheon at Cdn$229 million ($183.3 million). Patheon has yet to comment on the bid but "remains very confident in its business plan and continues to run the business as usual".